Roche Wins FDA Approval for New Wilserdly Breast Cancer Drug
Basel, Switzerland, November 16, 2026 Roche has announced that the U.S. Food and Drug Administration (FDA) has approved Wilserdly™...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease solid tumors targeted therapy
Basel, Switzerland, November 16, 2026 Roche has announced that the U.S. Food and Drug Administration (FDA) has approved Wilserdly™...
